(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 38.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,843.98%.
Endra Life Sciences's earnings in 2025 is -$8,765,336.On average, 3 Wall Street analysts forecast NDRA's earnings for 2025 to be -$5,743,220, with the lowest NDRA earnings forecast at -$5,517,995, and the highest NDRA earnings forecast at -$5,912,138.
In 2026, NDRA is forecast to generate -$6,825,832 in earnings, with the lowest earnings forecast at -$6,558,152 and the highest earnings forecast at -$7,026,592.